Annovis Bio, Inc.
ANVS •
Sell Open
Signal type
Sell
Status
Open
Open Price
$1.61
Stop Loss
$2.86
Performance
-7.45%
Days Open
6
Signal Setup
Signal Type Sell
Status Open
Open Date Apr 9, 2026
Open Price $1.61
Stop Loss $2.86
Timespan Day
Company Profile
Name Annovis Bio, Inc.
Ticker ANVS
Market Cap $42.29M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.73
List Date Jan 29, 2020
Description
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Website Open Company Website